Price Chart

Profile

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
URL https://www.aviditybiosciences.com
Investor Relations URL https://aviditybiosciences.investorroom.com/
HQ State/Province California
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Feb. 28, 2025 (est.)
Last Earnings Release Nov. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
URL https://www.aviditybiosciences.com
Investor Relations URL https://aviditybiosciences.investorroom.com/
HQ State/Province California
Sector Health Care
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Feb. 28, 2025 (est.)
Last Earnings Release Nov. 07, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A